The mediators regulating this transport are yet to be discovered and described, but the existing load of evidence suggests that inflammation, diabetes and triglycerides enhance insulin transport to the CNS, while aging, obesity, fasting and Alzheimer’s disease weaken it [18,19]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.